ライフサイエンスコーパス: adherence

1 to be favorable options for improving statin adherence.

2 Short-course regimens may improve adherence.

3 ceived a refill, and 900 (27%) self-reported adherence.

4 ard patients with such risk factors for poor adherence.

5 nts with HIV live, supporting their improved adherence.

6 -linked glycosylation of E-cadherin and cell adherence.

7 ues of safety and problems of poor treatment adherence.

8 ines both the abundance and location of EAEC adherence.

9 ls adjusted for clinical characteristics and adherence.

10 analysed factors associated with uptake and adherence.

11 educational intervention was able to improve adherence.

12 en administration route to promote long-term adherence.

13 opouts due to adverse effects, and treatment adherence.

14 ree-to-five-year regimens, enhancing patient adherence.

15 urine-based TFV assays to assess recent TDF adherence.

16 ained by differential antiretroviral therapy adherence.

17 ul program elements contributing to improved adherence.

18 stems are being developed to improve patient adherence.

19 NO) in 17 studies for inhaled corticosteroid adherence.

20 gnificant improvement in glaucoma medication adherence.

21 nt rate, medication adherence and procedural adherence.

22 0.67-0.92; P = .003) significantly impacted adherence.

23 ategy for monitoring tuberculosis medication adherence.

24 c visual input, while objectively monitoring adherence.

25 t of an evidence-based threshold for optimal adherence.

26 be an important consideration when assessing adherence.

27 hange in electronically monitored medication adherence.

28 progression, asthma occurrence, and therapy adherence.

29 can be optimized to increase ICU Liberation adherence.

30 rate" adherence (4 doses/week); or (3) "low" adherence (2 doses/week).

31 "perfect" adherence (daily); (2) "moderate" adherence (4 doses/week); or (3) "low" adherence (2 dose

32 Daily HH adherence 60 days prior and 90 days following outbreak o

33 ews shared on social media and to assess how adherence affects reader engagement.

34 Median adherence was 92%, with higher adherence among those receiving once-daily vs twice-dail

35 Interventions seeking to improve ART adherence among WLHIV should consider and address the ro

36 es they can access, (d) active monitoring of adherence and (e) discussing any implications for furthe

37 icipants, 20.0% (n = 147) self-reported poor adherence and 6.1% (n = 45) had EHR documentation of poo

38 on modulating therapeutics, even with proper adherence and acceptable tolerability, are not effective

39 zation run-in periods to improve participant adherence and assess responses to study interventions pr

40 ow that production of AAF/II is critical for adherence and barrier disruption in human colonoids, sug

41 found that intensified patient care improved adherence and decreased levels of total serum cholestero

42 -amino HMOs significantly inhibits bacterial adherence and eliminates the ability of both microbes to

43 d CD16+ newborn monocytes demonstrated lower adherence and extravasation as compared to adults.

44 ationships-families could modify barriers to adherence and foster positive views about self-managemen

45 o their wellbeing and antiretroviral therapy adherence and have poor treatment outcomes.

46 focused on overcoming barriers to medication adherence and included cues to action, statements relate

47 tegrin-blocking mAb or cilengitide inhibited adherence and invasion by staphylococci, suggesting that

48 pstS loss significantly decreased bacterial adherence and invasion into A549 cells and increased A54

49 ects of type I and type II IFNs on S. aureus adherence and invasion.

50 roviding insight into its effect on cellular adherence and migration, as well the basis of TMTC3-asso

51 and safety and demonstrated improvements in adherence and other patient outcomes.

52 Awareness of factors related to poor patient adherence and persistence in nAMD could help identify at

53 in atrial fibrillation (AF) is dependent on adherence and persistence in the real-world setting.

54 Suboptimal adherence and persistence to DOACs was common in patient

55 lementation outcomes often suggest poor PrEP adherence and persistence; however, this intervention is

56 en coach and patient to identify barriers to adherence and possible solutions.

57 was assessed as recruitment rate, medication adherence and procedural adherence.

58 nificant improvements for inhaler technique, adherence and quality of life.

59 n engaging, personalized therapy may improve adherence and treatment outcomes in the home.

60 f 48 years; 421 and 649 were included in the adherence and VS analyses, respectively.

61 the low observed event rate, as well as low adherence and wide range of treatment durations in the C

62 curity may be associated with suboptimal ART adherence and/or drug absorption.

63 enerally attributed to incomplete medication adherence and/or drug resistance.

64 n damage, due to vasoconstriction, leukocyte adherence, and activation of the immune response.

65 studies as a measure of oral corticosteroid adherence, and fractional exhaled nitric oxide (FeNO) in

66 e needed to combat viral resistance, improve adherence, and mitigate toxicities.

67 lot trial assessed the safety, tolerability, adherence, and pharmacodynamics of two doses of NaHCO(3)

68 tion therapy would mean less need for strict adherence, and reduced risk of bacterial resistance.

69 emographics, barriers to glaucoma medication adherence, and self-adherence (measured by the Morisky a

70 en stratified into groups based on change in adherence, and thematic differences between groups were

71 Usability, adherence, anxiety and anaphylaxis episodes were evaluat

72 Targeted interventions facilitating patient adherence are needed and have the potential to improve s

73 e were significantly different between the 3 adherence arms for plasma (P < .0001) and urine (P = .00

74 Lower adherence as measured using the MPR was strongly associa

75 ients with tuberculosis, we compared 99DOTS' adherence assessments against results of urine isoniazid

76 t was significantly associated with dual non-adherence at 6-months.

77 ibited negative serology and appropriate GFD adherence based on the questionnaire.

78 unotherapy regimes are marketed but have low adherence because they are expensive, complex, and time-

79 Higher MLVI indicates worse adherence behavior; values >=2.5 are predictive of late

80 evere vitreous hemorrhage, a point of strong adherence between a old hemorrhage and retinal surface w

81 monstrated significantly enhanced intestinal adherence, biofilm formation, and pro-inflammatory inter

82 f pilins observed in TEM and reduced surface adherence but still adsorb SSV9.

83 toring is a validated method of measuring HH adherence, but data demonstrating the clinical impact of

84 ate concentrations and create benchmarks for adherence categories.

85 Compared to adherent patients, dual-adherence challenged patients struggled to prioritize tr

86 ring (EDM) device could empirically identify adherence-challenged patients and that a mixed-methods a

87 itize treatment and lacked support, and dual adherence-challenged patients experienced higher rates o

88 d DR-TB HIV patients were identified as dual adherence-challenged.

89 ined for outbreak had significantly lower HH adherence compared to control units (IRR of 0.91 (95% CI

90 t parsing also self-reported poor medication adherence compared to the 20.0% by self-report overall (

91 glaucoma medication, who self-reported poor adherence) completed a baseline survey that assessed the

92 Management strategies that emphasize adherence counseling while delaying ART switch may promo

93 bited a greater change in FBS than their low-adherence counterparts: 0.30 points (95% confidence inte

94 e controlled TDF/FTC dosing as (1) "perfect" adherence (daily); (2) "moderate" adherence (4 doses/wee

95 ongoing dietary support, even though dietary adherence declined rapidly.

96 Adherence decreased during therapy.

97 eye drops, and had poor glaucoma medication adherence (defined as taking <=80% of prescribed medicat

98 3%) were administered in accordance with the adherence definition of this study.

99 comes were mortality, disability, medication adherence, depression, cognition, self-rated health, fat

100 exploratory, observational analysis examined adherence, dietary intake, weight loss, and metabolic ou

101 ples from individuals reporting HIV risk and adherence during follow-up, and analysed factors associa

102 Both treatments were well tolerated and adherence during the study was high.

103 vor SCP possession is associated with better adherence, few survivors and PCPs have one.

104 utative virulence genes encoding aggregative adherence fimbriae, E. coli common pilus, flagellin and

105 Separate EDM devices measured adherence for bedaquiline and ART.

106 long-acting formulation (RPV LA) to improve adherence for preexposure prophylaxis (PrEP) to prevent

107 the change of KAH between the high- and low-adherence groups was 3.72 points (95% CI: 1.71 to 5.73;

108 ions did not differ between the 3 randomized adherence groups.

109 e found that patients with high ABCDE bundle adherence (>= 60%) had significantly decreased odds of i

110 had drug concentrations consistent with poor adherence, highlighting the need for novel approaches an

111 tool, 22 of the 45 patients (48.9%) with non-adherence identified by text parsing also self-reported

112 Medication adherence improved from 59.9% at baseline to 81.3% (P <

113 peptides (GIP) as a biomarker monitoring GFD adherence in celiac patients and to evaluate the concord

114 extual tools to maximize coverage and intake adherence in programs using SQ-LNS.

115 inhibitors that not only target stemness and adherence independent growth of lung cancer cells but th

116 Asthma preventer medication non-adherence is strongly associated with poor asthma contro

117 Patients with low adherence (<85%) to both bedaquiline and ART were identi

118 e and cortisol levels commonly being used as adherence markers in clinical practice, further work is

119 P testing as an assessment technique for GFD adherence may help in ascertaining dietary compliance an

120 One-dimensional measures of adherence may ignore clinically important patterns of me

121 ent of participants showed an improvement in adherence (mean relative improvement, 21.4%; SD, 16.5%;

122 s to glaucoma medication adherence, and self-adherence (measured by the Morisky adherence scale) befo

123 We demonstrate the use of adherence measures towards a three-group categorization

124 Five adherence measures were extracted: the percentage of dos

125 ion doses assessed via electronic medication adherence monitors) who completed the 7-month SEE Progra

126 Lack of adherence (nonadherence) or undertreatment (nonpersisten

127 th baseline period; participants with median adherence of <=80% were enrolled in the SEE program.

128 irway epithelial cells resulted in increased adherence of NTHI, due in part to augmented expression o

129 some generic issues related to adoption and adherence of therapeutic interventions.

130 order to determine the consequences of EAEC adherence on epithelial barrier integrity, colonoid mono

131 mate the potential effect of improved bundle adherence on healthcare costs and quality-adjusted life-

132 on, we determined the impact of ABCDE bundle adherence on inpatient and 1-year mortality, quality-adj

133 odels to determine the impact of high bundle adherence on inpatient mortality, discharge status, leng

134 ication yesterday?" The impact of medication adherence on mean deviation (MD) over time was assessed

135 .0) was inversely associated with medication adherence on univariate (P < .0001) and multivariate ana

136 general information about regional screening adherence, or in a usual care group in which physicians

137 Median adherence over 3 months was 74% +/- 21% (+/-standard dev

138 Main outcome measure was median percent adherence over 3 months.

139 6.1% (n = 45) had EHR documentation of poor adherence (P < .0001).

140 on were significantly associated with better adherence (P < .0001, P = .03).

141 atment drug use (P >.99), or imperfect daily adherence (P = .35) but was significantly associated wit

142 .5%) TGMs were administered with appropriate adherence (P = 0.047).

143 However, high-adherence participants to the intervention exhibited a g

144 Inconclusive results, missing data, variable adherence, patient-reported findings on home tests, no b

145 Individual study estimates of DOAC adherence/persistence rates have been discordant.

146 Problems with adherence, planning sex in advance, or side effects were

147 ntify areas of priorities and plan treatment adherence programs using surveillance data.

148 O-linked glycosylation and cadherin-mediated adherence, providing insight into its effect on cellular

149 oups, the FAMILIA trial highlights that high adherence rates to lifestyle interventions may improve h

150 ect measurement of drug levels in the blood, adherence rates to oral corticosteroids ranged from 47%

151 iral drug resistance, and high self-reported adherence rates, preventing unnecessary regimen changes.

152 Dosing adherence remains a crucial factor determining the final

153 ervention used in conjunction with automated adherence reminders.

154 fic sIgA led to bacterial agglutination, but adherence required interaction of agglutinated pneumococ

155 food challenge (5044 mg peanut protein), and adherence, safety, and mechanistic parameters were evalu

156 rds for patient relationships and education, adherence, safety, collection of data, documentation, an

157 and self-adherence (measured by the Morisky adherence scale) before and 6 weeks after intervention.

158 ns), electronic reminders, and hearing their adherence score (37 participants, 90 citations) were mos

159 ere were no significant associations between adherence scores and low-frequency threshold elevation.

160 Diet adherence scores for the Dietary Approaches to Stop Hype

161 Higher adherence scores were associated with lower risk of hear

162 mbinations of clinic-level factors, enhanced adherence services (aHR, 1.37; 95% confidence interval [

163 ion on care delivery (eg, clinical services, adherence services, patient monitoring services) and cli

164 tal emotional support may be protective; (c) Adherence-suboptimal adherence was associated with older

165 ided by this study can be used to guide PrEP adherence support in pregnant/postpartum African women.

166 reening plus 4 weekly home visits to provide adherence support or to standard clinic-based care in Da

167 or cryptococcal antigen (CrAg) combined with adherence support reduced all-cause mortality by 28%, co

168 Celiac disease Adherence Test (CDAT) is a valid English-language questi

169 ients who then self-reported poor medication adherence than an automated EHR pull alone but was limit

170 tly after 12 weeks of treatment, with higher adherence than that of available treatments.

171 nintentional and originates from barriers to adherence that are often multifactorial and complex.

172 ed 16.0% of patients (n = 188) below the set adherence threshold.

173 Additional studies to improve adherence through interventions that reduce biases and b

174 were- ((((((Compliance [Title/Abstract]) OR Adherence [Title/Abstract]) OR Compliant [Title/Abstract

175 The beneficial impact of adherence to a DASH diet on several metabolic conditions

176 als Follow-up Study, we found that long-term adherence to a dietary pattern associated with sulfur-me

177 y mass index (BMI) can be compensated for by adherence to a healthy diet and whether the effect on mo

178 and whether the effect on mortality by a low adherence to a healthy diet can be compensated for by a

179 Adherence to a healthy diet has been associated with red

180 Adherence to a healthy lifestyle and colonoscopy in the

181 mong these high polygenic score individuals, adherence to a healthy lifestyle or use of statins may o

182 e risk estimates consistently decreased with adherence to a healthy lifestyle.

183 rmined risk of CRC can be further reduced by adherence to a healthy lifestyle.

184 Adherence to a Mediterranean diet reduces the incidence

185 Pneumococcal adherence to adult human nasal fluid was seen only by is

186 Twice-weekly text reminders did not improve adherence to AIs.

187 Adherence to and invasion of epithelial and endothelial

188 multicenter PARIS registry (Patterns of Non-Adherence to Anti-Platelet Regimens in Stented Patients)

189 (odds ratio [OR], 3.7; P < .001), imperfect adherence to antiretroviral therapy (ART) (OR, 2.8; P <

190 V-1 RNA above 40 copies/mL) despite reported adherence to ART and the absence of drug resistance to t

191 However, the optimal method for measuring adherence to asthma therapy remains unclear.

192 tly need effective interventions to increase adherence to behaviours that individuals in communities

193 s large population of ICU patients with high adherence to chemoprophylaxis.

194 y data, medical comorbidities, insurance and adherence to cirrhosis quality care indicators were reco

195 SCP possession was associated with increased adherence to COG breast (22.3% v.

196 Among high-risk survivors, adherence to COG breast, colorectal, skin, and cardiac s

197 stic scintigraphy, there is heterogeneity in adherence to consensus guidelines.

198 TEACH is a promising intervention to improve adherence to COT guidelines without evident adverse cons

199 t clear public health messaging and rigorous adherence to COVID-19 prevention strategies in all obese

200 Among men, the average adherence to CT screening was 90.0%.

201 There is an inverse correlation between adherence to DASH diet and daytime sleepiness score.

202 Greater adherence to duty hour standards and efforts to improve

203 This shows that adherence to evidence-based criteria is likely to result

204 Calls for adherence to evidence-based medicine have emerged during

205 Percent adherence to follow-up appointments was alarmingly low,

206 ome metropolitan patient population improved adherence to follow-up eye care recommendations while re

207 plementation control and assessed effects on adherence to four different evidence-based quality indic

208 laucoma-related distress all predicted lower adherence to glaucoma medications.

209 care in cirrhosis is associated with higher adherence to guideline-recommended care and improves cli

210 findings reinforce prior observations of low adherence to guideline-recommended practices in smaller

211 We determined whether an audit on the adherence to guidelines for hospital-acquired pneumonia

212 -risk patients with FN and BSI, despite high adherence to guidelines.

213 adually decreased in association with higher adherence to healthful-PDI, regardless of genetic suscep

214 Adherence to healthy plant-based diets may be associated

215 Adherence to host intestinal cells mediated by ETEC fimb

216 ability index (MLVI), a surrogate measure of adherence to immunosuppression in pediatric liver transp

217 ocioeconomic deprivation was associated with adherence to immunosuppressive medications after liver t

218 Adherence to Infectious Diseases Society of America (IDS

219 ighborhood was significantly associated with adherence to initial diabetic retinopathy screening.

220 s spores both via faecal pellets and through adherence to its hydrophobic cuticle.

221 f-target side effects lead to dismal patient adherence to lifelong drug regimens.

222 Adherence to Nordic, portfolio, and low-salt diets also

223 This study demonstrated high adherence to once- and twice-daily DAA therapy among peo

224 We demonstrate how adherence to Open Science principles is key to the OTN c

225 i may be propelled towards pan-resistance by adherence to outdated international treatment guidelines

226 Greater adherence to PDI was associated with lower risk of eleva

227 nce of strategies for maintaining persistent adherence to PrEP and novel approaches to making PrEP se

228 Estimates of the cost-utility value of adherence to prescribed glaucoma medication are vital to

229 ses on the patient view of factors affecting adherence to prevention measures, particularly in commun

230 quired to self-manage their care but patient adherence to prevention strategies is a significant clin

231 ces that vary across hospitals could improve adherence to process measures or outcomes after in-hospi

232 Study design and adherence to quality criteria had a considerable impact

233 ity of these findings is complicated by poor adherence to reporting guidelines and high risk of bias,

234 Efforts should be made to improve adherence to screening guidelines, especially for vulner

235 to establish the dynamics of cell growth and adherence to simple growth laws.

236 Despite high coverage and high adherence to SMC, the incidence of hospitalisations or d

237 phic characteristics and different levels of adherence to social distancing is uncertain.

238 matic disease transmission, and age-specific adherence to social distancing measures.

239 that could be further minimized by stricter adherence to standard protocols.

240 tegies to improve patients' tolerance of and adherence to statins may enhance the effectiveness of dy

241 d, but ineligible patients, it is clear that adherence to strict definitions of resectable PDA is cha

242 lts provide empirical evidence that improved adherence to suicide-reporting guidelines may benefit no

243 Hence, we conducted a study to analyze adherence to suicide-reporting guidelines on news shared

244 he tamoxifen prescription, 55% self-reported adherence to tamoxifen.

245 was to evaluate the relation of prepregnancy adherence to the American Heart Association (AHA) diet r

246 from all initial procedures, irrespective of adherence to the assigned procedure, occurred in 29% of

247 r the course of the trial, resulting in poor adherence to the assigned study treatment and a reduced

248 y was to investigate the correlation between adherence to the DASH diet and daytime sleepiness score

249 be expected, participants with the greatest adherence to the DASH diet had significantly higher inta

250 Adherence to the DASH, Nordic, and portfolio diets effec

251 ternal consistency can be used for assessing adherence to the GFD in adult celiac patients in Iran.

252 questionnaire that is used for assessing the adherence to the GFD.

253 and a statistically significant increase in adherence to the implant maintenance routine was observe

254 Disrupting bacterial adherence to the intestinal surface could potentially ta

255 At week 26, study groups had similar adherence to the MedDiet but patients randomly assigned

256 itional logistic regression analyses, better adherence to the Mediterranean diet (highest compared wi

257 residual confounding from factors related to adherence to the monthly SMC schedule.

258 Vaccine failure was defined as TBE despite adherence to the recommended vaccination schedule with a

259 cyclic nature of cardiac motion, and better adherence to the stroke volume of the heart.

260 Greater adherence to the traditional vegetables pattern before p

261 This study suggests that better adherence to the traditional vegetables pattern before p

262 ing and support from study staff to maximize adherence to the training.

263 nce in support of limiting alcohol intake in adherence to the USDGA recommendations.

264 Given the prevalence of poor adherence to therapy and the biases of self-reporting ac

265 routine interventional practice and whether adherence to these thresholds is associated with better

266 ox proportional hazards modeling to evaluate adherence to this pattern among eligible individuals (n

267 ing frequency was not associated with better adherence to timely delivery of epinephrine or defibrill

268 versely, symptoms of depression may decrease adherence to treatment of both disorders.

269 Treatments for OUD may be limited by poor adherence to treatment recommendations and by high rates

270 Adherence to Western and prudent dietary patterns was si

271 The barriers to uptake of, and adherence to, current medications will need to be consid

272 f the fibrous consistency, irregularity, and adherences to the medial rectus muscle.

273 12 weeks thereafter), refills, self-reported adherence up to 72 weeks, and concentrations of tenofovi

274 re prophylaxis (PrEP) users face barriers to adherence using daily pills, which could be reduced by l

275 The aim of this study was to analyse adherence using the medication possession ration (MPR) a

276 The adherence VAS improved from 59.7 (95% CI, 54.0-65.3) to

277 Median adherence was 92%, with higher adherence among those rec

278 Adherence was 94 to 96% midway through treatment, with 2

279 Adherence was 96%.

280 Medication adherence was assessed by telephone from responses to th

281 Adherence was associated significantly with a known outp

282 High bundle adherence was associated with a 0.12 increase in quality

283 Worse medication adherence was associated with loss of MD over time (P =

284 may be protective; (c) Adherence-suboptimal adherence was associated with older age, barriers to med

285 Treatment adherence was better with 4 months of rifampin than 9 mo

286 Adherence was compared before and after the SEE program

287 Adherence was defined as administration of more than 75%

288 Adherence was linearly associated with favourable outcom

289 Medication adherence was modeled as a cumulative sum of the number

290 Participants' adherence was monitored electronically (AdhereTech, New

291 Adherence was monitored electronically for a 3-month bas

292 pointments was alarmingly low, and decreased adherence was observed with non-white race and increased

293 d outside the centers: Here, EAACI guideline adherence was only 37%.

294 ess than wild-type (WT) EAEC strain 042, and adherence was restored in a complemented strain.

295 s (ng/mL) for perfect, moderate, and low TDF adherence were 41 (26-52), 16 (14-19), and 4 (3-5) in pl

296 A total of 201 subjects with good dietary adherence were genotyped for 95 single nucleotide polymo

297 The completion rate and adherence were good, and the tolerance was acceptable; n

298 aking >=1 medication, who self-reported poor adherence were recruited from the University of Michigan

299 three-group categorization of medication non-adherence, which succinctly describes the diversity of p

300 ntravitreal ranibizumab 0.5 mg injections in adherence with local prescribing information.